PubMed · 1987 · 11 citations · 0 references
MedicineInfectious DiseasesPediatricsAntimicrobial PharmacologyAntimicrobial PharmacotherapyPediatric Infectious DiseasesAntifungal PharmacologyAntimicrobial DosingNeonatal Drug TherapyNeonatal InfectionsNeonatal Infectious DiseasesPediatric Antimicrobial TherapyAntimicrobial Therapy In InfantsDosing In Premature InfantsNeonatal Antifungal TherapyNeonatal Fungal InfectionPediatric Antifungal DosingPediatric Antifungal TherapyPediatric Antimicrobial Dosing
Amphotericin B (Amp-B) serum concentrations were determined in five infants with disseminated candidiasis. All patients had positive blood cultures for Candida and one patient had Candida albicans meningitis. Amp-B sterilized the blood and the cerebrospinal fluid within four to nine days. Total doses of Amp-B varied from 11.6-62.3 mg. There was no laboratory or clinical evidence of renal toxicity. Two infants died of causes unrelated to disseminated candidiasis. Disseminated candidiasis in premature infants was treated successfully with 0.5 mg/kg doses of Amp-B, but further studies with more evaluable cases are needed to confirm the correct dose.